Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Bispecific Antibody Therapeutics Contract Manufacturing Market to reach USD 63.38 billion by the end of 2030.

Global Bispecific Antibody Therapeutics Contract Manufacturing Market Size Study & Forecast, by Indication (Cancer, Infectious Diseases, Autoinflammatory and autoimmune diseases, CNS Conditions, Others), by Route of Administration (Intravenous, Subcutaneous, Others), by End-use (Pharmaceutical Companies, Biopharmaceutical Companies, Others), and Regional Analysis, 2023-2030

Product Code: HLSDT-47729125
Publish Date: 30-10-2023
Page: 200

Global Bispecific Antibody Therapeutics Contract Manufacturing Market is valued at approximately USD 5.29 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 36.4% over the forecast period 2023-2030. Bispecific antibody therapeutics contract manufacturing refers to the outsourcing of the manufacturing processes involved in producing bispecific antibodies to specialized contract manufacturing organizations (CMOs). Bispecific antibodies are a group of therapeutic molecules created to concurrently target two distinct antigens, which are often located on the surface of cells implicated in illnesses including cancer, autoimmune disorders, and infectious diseases. These antibodies have huge potential due to their capacity to increase therapy specificity and effectiveness. The rise in incidences of chronic diseases such as cancer and autoimmune disorders, surging demand for personalized medicine, as well as globalization of the biopharmaceutical industry are the key factors that are spurring the market demand across the globe.

In addition, a robust pipeline of bispecific antibody therapeutics is witnessing a positive impact on the market growth in the global market. Biopharmaceutical companies often outsource manufacturing to dedicated contract manufacturers to accelerate development timelines in various stages of development. According to BioPharm International, the versatility of bispecific antibody therapeutics extends across various clinical domains such as tumor immunotherapy, neurological disorders, targeted drug delivery, and infectious diseases. As per the BioPharm International, bispecific antibody therapeutics ideally have broad clinical applications in tumor immunotherapy, targeted drug delivery, neurological disorders, or infective diseases. Also, the surge in enthusiasm for bispecific antibody research, coupled with heightened investments in immunotherapy, novel clinical trials, and regulatory approvals is resulting in market expansion. According to the results of the phase I/II clinical trial, individuals with refractory or relapsed multiple myeloma witnessed a 90.5% response rate to the bispecific antibody REGN5459. The outcomes of the bispecific antibody studies in humans were also reported at the annual meeting of the American Association for Cancer Research in 2023. The U.S. FDA has approved the first bispecific antibody targeting BCMA & CD3 for patients with persistent multiple myeloma as a result of the REGN5459 new results. Similarly, according to Sino Biological, Catumaxomab, the first licensed bispecific antibody (bsAB), was among the six bsABs for cancer immunotherapy that the EMA and/or FDA approved as of 2022. Thus, these aforementioned factors are propelling the growth of the bispecific antibody therapeutics Contract Manufacturing Market during the estimated period. Moreover, the ongoing research activities in bispecific antibody therapeutics, as well as technological advancements in biotechnology present various lucrative opportunities over the forecast years. However, the regulatory challenges and the high cost associated with the manufacturing of bispecific antibodies are hampering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Bispecific Antibody Therapeutics Contract Manufacturing Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the high cost of drug development, rising number of clinical trials, technological advancements in biotechnology, and growing research activities. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The increase in demand for bispecific antibodies, rising demand for personalized medicine, coupled with the growing prevalence of cancer and the need for new medications in major countries including China, India, and Japan. are significantly propelling the market demand across the region.

Major market players included in this report are:
Lonza Group AG
F. Hoffmann-La Roche Ltd
Creative Biolabs Inc.
AbbVie Inc.
Amgen Inc.
Janssen Global Services, LLC
Johnson & Johnson Services, Inc
IQVIA Holdings Inc.
WuXi Biologics Holdings Co. Ltd.
Sino Biological Inc.

Recent Developments in the Market:
Ø In June 2022, The European Commission issued a conditional marketing authorization for the Roche company’s CD20xCD3 T-cell binding bsAB Lunsumio (mosunetuzumab). It is used to treat follicular lymphoma that has relapsed or is resistant among individuals who have already had two systemic therapies.

Global Bispecific Antibody Therapeutics Contract Manufacturing Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Indication, Route of Administration, End-use, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Indication:
Cancer
Infectious Diseases
Autoinflammatory and autoimmune diseases
CNS Conditions
Others

By Route of Administration:
Intravenous
Subcutaneous
Others

By End-use:
Pharmaceutical Companies
Biopharmaceutical Companies
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Bispecific Antibody Therapeutics Contract Manufacturing Market, by Region, 2020-2030 (USD Billion)
1.2.2. Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2020-2030 (USD Billion)
1.2.3. Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration, 2020-2030 (USD Billion)
1.2.4. Bispecific Antibody Therapeutics Contract Manufacturing Market, by End-use, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Bispecific Antibody Therapeutics Contract Manufacturing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Bispecific Antibody Therapeutics Contract Manufacturing Market Dynamics
3.1. Bispecific Antibody Therapeutics Contract Manufacturing Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Robust pipeline of bispecific antibody therapeutics
3.1.1.2. Rise in incidences of chronic diseases such as cancer and autoimmune disorders
3.1.2. Market Challenges
3.1.2.1. Regulatory challenges
3.1.2.2. High cost associated with the manufacturing of bispecific antibodies
3.1.3. Market Opportunities
3.1.3.1. Ongoing research activities in bispecific antibody therapeutics
3.1.3.2. Technological advancements in biotechnology
Chapter 4. Global Bispecific Antibody Therapeutics Contract Manufacturing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication
5.1. Market Snapshot
5.2. Global Bispecific Antibody Therapeutics Contract Manufacturing Market by Indication, Performance – Potential Analysis
5.3. Global Bispecific Antibody Therapeutics Contract Manufacturing Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
5.4. Bispecific Antibody Therapeutics Contract Manufacturing Market, Sub Segment Analysis
5.4.1. Cancer
5.4.2. Infectious Diseases
5.4.3. Autoinflammatory and autoimmune diseases
5.4.4. CNS Conditions
5.4.5. Others
Chapter 6. Global Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration
6.1. Market Snapshot
6.2. Global Bispecific Antibody Therapeutics Contract Manufacturing Market by Route of Administration, Performance – Potential Analysis
6.3. Global Bispecific Antibody Therapeutics Contract Manufacturing Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
6.4. Bispecific Antibody Therapeutics Contract Manufacturing Market, Sub Segment Analysis
6.4.1. Intravenous
6.4.2. Subcutaneous
6.4.3. Others
Chapter 7. Global Bispecific Antibody Therapeutics Contract Manufacturing Market, by End-use
7.1. Market Snapshot
7.2. Global Bispecific Antibody Therapeutics Contract Manufacturing Market by End-use, Performance – Potential Analysis
7.3. Global Bispecific Antibody Therapeutics Contract Manufacturing Market Estimates & Forecasts by End-use 2020-2030 (USD Billion)
7.4. Bispecific Antibody Therapeutics Contract Manufacturing Market, Sub Segment Analysis
7.4.1. Pharmaceutical Companies
7.4.2. Biopharmaceutical Companies
7.4.3. Others
Chapter 8. Global Bispecific Antibody Therapeutics Contract Manufacturing Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Bispecific Antibody Therapeutics Contract Manufacturing Market, Regional Market Snapshot
8.4. North America Bispecific Antibody Therapeutics Contract Manufacturing Market
8.4.1. U.S. Bispecific Antibody Therapeutics Contract Manufacturing Market
8.4.1.1. Indication breakdown estimates & forecasts, 2020-2030
8.4.1.2. Route of Administration breakdown estimates & forecasts, 2020-2030
8.4.1.3. End-use breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Bispecific Antibody Therapeutics Contract Manufacturing Market
8.5. Europe Bispecific Antibody Therapeutics Contract Manufacturing Market Snapshot
8.5.1. U.K. Bispecific Antibody Therapeutics Contract Manufacturing Market
8.5.2. Germany Bispecific Antibody Therapeutics Contract Manufacturing Market
8.5.3. France Bispecific Antibody Therapeutics Contract Manufacturing Market
8.5.4. Spain Bispecific Antibody Therapeutics Contract Manufacturing Market
8.5.5. Italy Bispecific Antibody Therapeutics Contract Manufacturing Market
8.5.6. Rest of Europe Bispecific Antibody Therapeutics Contract Manufacturing Market
8.6. Asia-Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market Snapshot
8.6.1. China Bispecific Antibody Therapeutics Contract Manufacturing Market
8.6.2. India Bispecific Antibody Therapeutics Contract Manufacturing Market
8.6.3. Japan Bispecific Antibody Therapeutics Contract Manufacturing Market
8.6.4. Australia Bispecific Antibody Therapeutics Contract Manufacturing Market
8.6.5. South Korea Bispecific Antibody Therapeutics Contract Manufacturing Market
8.6.6. Rest of Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market
8.7. Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market Snapshot
8.7.1. Brazil Bispecific Antibody Therapeutics Contract Manufacturing Market
8.7.2. Mexico Bispecific Antibody Therapeutics Contract Manufacturing Market
8.8. Middle East & Africa Bispecific Antibody Therapeutics Contract Manufacturing Market
8.8.1. Saudi Arabia Bispecific Antibody Therapeutics Contract Manufacturing Market
8.8.2. South Africa Bispecific Antibody Therapeutics Contract Manufacturing Market
8.8.3. Rest of Middle East & Africa Bispecific Antibody Therapeutics Contract Manufacturing Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Lonza Group AG
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. F. Hoffmann-La Roche Ltd
9.3.3. Creative Biolabs Inc.
9.3.4. AbbVie Inc.
9.3.5. Amgen Inc.
9.3.6. Janssen Global Services, LLC
9.3.7. Johnson & Johnson Services, Inc
9.3.8. IQVIA Holdings Inc.
9.3.9. WuXi Biologics Holdings Co. Ltd.
9.3.10. Sino Biological Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now